-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Hinge Health, Lowers Price Target to $60

Benzinga·01/05/2026 15:04:36
语音播报
Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and lowers the price target from $65 to $60.